William P. Sheridan
2011
In 2011, William P. Sheridan earned a total compensation of $722.4K as Senior Vice President and Chief Medical Officer at BioCryst Pharmaceuticals, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $119,604 |
|---|---|
| Option Awards | $152,350 |
| Salary | $396,743 |
| Stock Awards | $41,500 |
| Other | $12,250 |
| Total | $722,447 |
Sheridan received $396.7K in salary, accounting for 55% of the total pay in 2011.
Sheridan also received $119.6K in non-equity incentive plan, $152.4K in option awards, $41.5K in stock awards and $12.3K in other compensation.
Rankings
In 2011, William P. Sheridan's compensation ranked 6,821st out of 10,747 executives tracked by ExecPay. In other words, Sheridan earned more than 36.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,821 out of 10,747 | 37th |
Division Manufacturing | 2,484 out of 3,960 | 37th |
Major group Chemicals And Allied Products | 590 out of 1,033 | 43rd |
Industry group Drugs | 394 out of 781 | 50th |
Industry Biological Products, Except Diagnostic Substances | 60 out of 157 | 62nd |
Source: SEC filing on March 21, 2014.
Sheridan's colleagues
We found five more compensation records of executives who worked with William P. Sheridan at BioCryst Pharmaceuticals in 2011.
2011
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2011
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
2011
Yarlagadda Babu
BioCryst Pharmaceuticals
Senior Vice President of Drug Discovery
2011
David McCullough
BioCryst Pharmaceuticals
Vice President, Strategic Planning, Commercialization and Corporate Development
2011
Stuart Grant
BioCryst Pharmaceuticals